New research analyzing an online survey of 1,633 respondents found a 15% recent use of doxycycline post- and pre‐exposure ...

Black men who were identified as sexual minorities were more receptive to long-acting injectable pre-exposure prophylaxis ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Gilead Sciences, Inc. (NASDAQ: GILD) is one of the. The company announced that the US FDA approved Yeztugo ® (lenacapavir), ...

"Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention" was originally created and published by ...

HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally ...

As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...

The Department of Health (DOH) wants to declare HIV a national public health emergency. On deeper analysis, a 500-percent increase in HIV cases among Filipinos aged 15 to 25—some as young as ...

Introduction The research literature addressing pre-exposure prophylaxis (PrEP) has increased considerably over the last decade. To better understand the research areas and explore research gaps, we ...

TV presenter Trisha Goddard on her career as the British Oprah and living with cancer.

LONDON, June 19, 2025 /PRNewswire/ -- The Elton John AIDS Foundation, together with Fast-Track Cities, Gilead Sciences and ViiV Healthcare, is investing over £1 million in two innovation pilots ...